SP101, a novel synthetic compound reduces the drug resistance of EGFR(T790M) and cancerous stemness in non-small cell lung carcinoma

Thumbnail Image

Date

2016-04-01

Authors

Journal Title

Journal ISSN

Volume Title

Publisher

DOI

Abstract

Description

Keywords

Citation

URI

https://ir.lib.nycu.edu.tw/handle/11536/145847

Collections

期刊論文;;Articles

Endorsement

Review

Supplemented By

Referenced By